The origin-of-cell harboring cancer-driving mutations in human glioblastoma
Glioblastoma (GBM) is the most common and aggressive form of human adult brain malignancy. The identification of the cell of origin harboring cancer-driver mutations is the fundamental issue for understanding the nature of GBM and developing the effective therapeutic target. It has been a long-term...
Saved in:
Published in | BMB reports Vol. 51; no. 10; pp. 481 - 483 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korean Society for Biochemistry and Molecular Biology
01.10.2018
생화학분자생물학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1976-6696 1976-670X |
DOI | 10.5483/BMBRep.2018.51.10.233 |
Cover
Abstract | Glioblastoma (GBM) is the most common and aggressive form of human adult brain malignancy. The identification of the cell of origin harboring cancer-driver mutations is the fundamental issue for understanding the nature of GBM and developing the effective therapeutic target. It has been a long-term hypothesis that neural stem cells in the subventricular zone (SVZ) might be the origin-of-cells in human glioblastoma since they are known to have life-long proliferative activity and acquire somatic mutations. However, the cell of origin for GBM remains controversial due to lack of direct evidence thereof in human GBM. Our recent study using various sequencing techniques in triple matched samples such as tumor-free SVZ, tumor, and normal tissues from human patients identified the clonal relationship of driver mutations between GBM and tumor-free SVZ harboring neural stem cells (NSCs). Tumor-free SVZ tissue away from the tumor contained low-level GBM driver mutations (as low as 1% allelic frequency) that were found in the dominant clones in its matching tumors. Moreover, via single-cell sequencing and microdissection, it was discovered that astrocyte-like NSCs accumulating driver mutations evolved into GBM with clonal expansion. Furthermore, mutagenesis of cancer-driving genes of NSCs in mice leads to migration of mutant cells from SVZ to distant brain and development of high-grade glioma through the aberrant growth of oligodendrocyte precursor lineage. Altogether, the present study provides the first direct evidence that NSCs in human SVZ is the cell of origin that develops the driver mutations of GBM. [BMB Reports 2018; 51(10): 481-483]. |
---|---|
AbstractList | Glioblastoma (GBM) is the most common and aggressive form of human adult brain malignancy. The identification of the cell of origin harboring cancer-driver mutations is the fundamental issue for understanding the nature of GBM and developing the effective therapeutic target. It has been a long-term hypothesis that neural stem cells in the subventricular zone (SVZ) might be the origin-of-cells in human glioblastoma since they are known to have life-long proliferative activity and acquire somatic mutations. However, the cell of origin for GBM remains controversial due to lack of direct evidence thereof in human GBM. Our recent study using various sequencing techniques in triple matched samples such as tumor-free SVZ, tumor, and normal tissues from human patients identified the clonal relationship of driver mutations between GBM and tumor-free SVZ harboring neural stem cells (NSCs). Tumor-free SVZ tissue away from the tumor contained low-level GBM driver mutations (as low as 1% allelic frequency) that were found in the dominant clones in its matching tumors. Moreover, via single-cell sequencing and microdissection, it was discovered that astrocyte-like NSCs accumulating driver mutations evolved into GBM with clonal expansion. Furthermore, mutagenesis of cancer-driving genes of NSCs in mice leads to migration of mutant cells from SVZ to distant brain and development of high-grade glioma through the aberrant growth of oligodendrocyte precursor lineage. Altogether, the present study provides the first direct evidence that NSCs in human SVZ is the cell of origin that develops the driver mutations of GBM. Glioblastoma (GBM) is the most common and aggressive form of human adult brain malignancy. The identification of the cell of origin harboring cancer-driver mutations is the fundamental issue for understanding the nature of GBM and developing the effective therapeutic target. It has been a long-term hypothesis that neural stem cells in the subventricular zone (SVZ) might be the origin-of-cells in human glioblastoma since they are known to have life-long proliferative activity and acquire somatic mutations. However, the cell of origin for GBM remains controversial due to lack of direct evidence thereof in human GBM. Our recent study using various sequencing techniques in triple matched samples such as tumor-free SVZ, tumor, and normal tissues from human patients identified the clonal relationship of driver mutations between GBM and tumor-free SVZ harboring neural stem cells (NSCs). Tumor-free SVZ tissue away from the tumor contained low-level GBM driver mutations (as low as 1% allelic frequency) that were found in the dominant clones in its matching tumors. Moreover, via single-cell sequencing and microdissection, it was discovered that astrocyte-like NSCs accumulating driver mutations evolved into GBM with clonal expansion. Furthermore, mutagenesis of cancer-driving genes of NSCs in mice leads to migration of mutant cells from SVZ to distant brain and development of high-grade glioma through the aberrant growth of oligodendrocyte precursor lineage. Altogether, the present study provides the first direct evidence that NSCs in human SVZ is the cell of origin that develops the driver mutations of GBM. KCI Citation Count: 0 Glioblastoma (GBM) is the most common and aggressive form of human adult brain malignancy. The identification of the cell of origin harboring cancer-driver mutations is the fundamental issue for understanding the nature of GBM and developing the effective therapeutic target. It has been a long-term hypothesis that neural stem cells in the subventricular zone (SVZ) might be the origin-of-cells in human glioblastoma since they are known to have life-long proliferative activity and acquire somatic mutations. However, the cell of origin for GBM remains controversial due to lack of direct evidence thereof in human GBM. Our recent study using various sequencing techniques in triple matched samples such as tumor-free SVZ, tumor, and normal tissues from human patients identified the clonal relationship of driver mutations between GBM and tumor-free SVZ harboring neural stem cells (NSCs). Tumor-free SVZ tissue away from the tumor contained low-level GBM driver mutations (as low as 1% allelic frequency) that were found in the dominant clones in its matching tumors. Moreover, via single-cell sequencing and microdissection, it was discovered that astrocyte-like NSCs accumulating driver mutations evolved into GBM with clonal expansion. Furthermore, mutagenesis of cancer-driving genes of NSCs in mice leads to migration of mutant cells from SVZ to distant brain and development of high-grade glioma through the aberrant growth of oligodendrocyte precursor lineage. Altogether, the present study provides the first direct evidence that NSCs in human SVZ is the cell of origin that develops the driver mutations of GBM. [BMB Reports 2018; 51(10): 481-483]. |
Author | Lee, Jeong Ho Lee, Joo Ho |
AuthorAffiliation | 1 Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Korea 2 Graduate School of Medical Science and Engineering, KAIST, Daejeon 34141, Korea |
AuthorAffiliation_xml | – name: 2 Graduate School of Medical Science and Engineering, KAIST, Daejeon 34141, Korea – name: 1 Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Korea |
Author_xml | – sequence: 1 givenname: Joo Ho surname: Lee fullname: Lee, Joo Ho organization: Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Korea – sequence: 2 givenname: Jeong Ho surname: Lee fullname: Lee, Jeong Ho organization: Graduate School of Medical Science and Engineering, KAIST, Daejeon 34141, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30269745$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002398103$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNpVkN1LwzAUxYNM3Jz7E5S--tCaNM1HX4Rt-DGcCGOCbyVN0jasTUbaDfzvrZsTfTr3nnvO7-FegoF1VgNwjWBEEo7vZq-zld5GMUQ8Iijq7RjjMzBCKaMhZfBjcJppSodg0rYmhwRjRhlPL8AQw5imLCEj8LKudOC8KY0NXRFKXddBJXzeW7YMpLBS-1B5s_9em10nOuNsGxgbVLtG2KCsjctr0XauEVfgvBB1qyc_Ogbvjw_r-XO4fHtazKfLUCYJ6UIiCpZQrpHkKo-LXjTSlDKVF4pyoajgaW9ApRItGcSKi5xAyBTLJUVU4zG4PXKtL7KNNJkT5qClyzY-m67Wi4xRRCDCffb-mN3u8kYrqW3nRZ1tvWmE_zw0_1-sqXrOPqMxJpCnPeDmL-C3eXoh_gIX5Xn5 |
CitedBy_id | crossref_primary_10_1007_s11060_025_04965_7 crossref_primary_10_4252_wjsc_v13_i7_877 crossref_primary_10_1016_j_tins_2024_07_004 crossref_primary_10_1109_TMI_2020_3024264 crossref_primary_10_12786_bn_2022_15_e24 crossref_primary_10_5306_wjco_v15_i2_178 crossref_primary_10_1088_1361_6420_ab649c crossref_primary_10_1186_s12943_025_02273_2 crossref_primary_10_1002_mc_23720 |
ContentType | Journal Article |
Copyright | Copyright © 2018 by the The Korean Society for Biochemistry and Molecular Biology 2018 |
Copyright_xml | – notice: Copyright © 2018 by the The Korean Society for Biochemistry and Molecular Biology 2018 |
DBID | CGR CUY CVF ECM EIF NPM 5PM ACYCR |
DOI | 10.5483/BMBRep.2018.51.10.233 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1976-670X |
EndPage | 483 |
ExternalDocumentID | oai_kci_go_kr_ARTI_7615013 PMC6235089 30269745 |
Genre | News |
GroupedDBID | .UV ALMA_UNASSIGNED_HOLDINGS CGR CUY CVF ECM EIF NPM --- 23N 2WC 5GY 5PM 5VS 87B 9ZL AAFWJ ACGFO ACYCR ADBBV AENEX AFPKN AOIJS BAWUL BCNDV DIK E3Z F5P GROUPED_DOAJ GX1 HH5 HYE HZB JDI KQ8 OVT RNS RPM TR2 53G 85H IPNFZ M~E OK1 RIG |
ID | FETCH-LOGICAL-c445t-5af7468e1c8db2f1c8e1e667dbfd68ad6a891e60dd4ec703d8ab5007d7bc616e3 |
ISSN | 1976-6696 |
IngestDate | Tue Nov 21 21:47:25 EST 2023 Thu Aug 21 14:01:05 EDT 2025 Fri Feb 23 03:39:21 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c445t-5af7468e1c8db2f1c8e1e667dbfd68ad6a891e60dd4ec703d8ab5007d7bc616e3 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC6235089 |
PMID | 30269745 |
PageCount | 3 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_7615013 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6235089 pubmed_primary_30269745 |
PublicationCentury | 2000 |
PublicationDate | 2018-10-01 |
PublicationDateYYYYMMDD | 2018-10-01 |
PublicationDate_xml | – month: 10 year: 2018 text: 2018-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | BMB reports |
PublicationTitleAlternate | BMB Rep |
PublicationYear | 2018 |
Publisher | Korean Society for Biochemistry and Molecular Biology 생화학분자생물학회 |
Publisher_xml | – name: Korean Society for Biochemistry and Molecular Biology – name: 생화학분자생물학회 |
SSID | ssib053376789 ssj0061272 |
Score | 2.2420666 |
Snippet | Glioblastoma (GBM) is the most common and aggressive form of human adult brain malignancy. The identification of the cell of origin harboring cancer-driver... |
SourceID | nrf pubmedcentral pubmed |
SourceType | Open Website Open Access Repository Index Database |
StartPage | 481 |
SubjectTerms | Astrocytes - pathology Glioblastoma - genetics Glioblastoma - pathology Humans Lateral Ventricles - pathology Mutation - genetics Neural Stem Cells - metabolism Neural Stem Cells - pathology 화학 |
Title | The origin-of-cell harboring cancer-driving mutations in human glioblastoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30269745 https://pubmed.ncbi.nlm.nih.gov/PMC6235089 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002398103 |
Volume | 51 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | BMB Reports, 2018, 51(10), , pp.481-483 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb5swFLbSTtp6mbrf2dYKTbtVziBgG45r1Crb1KqHVsoN-WeL2kKFiDTtr98zNgSiHrZeAL0QQvwe9vfM5_ch9NUwoyMtDObacAz5Rox5qOCIcCMM4GsjW4LsOV1eJT9XZDWZ_B6wltaNmMk_j64reYpXwQZ-tatk_8Oz_UXBAMfgX9iCh2H7zz52yla4MtjOwR_d8Fo4Tp20_qyxqot2zuB-3Wx4406Z7_quqASg56bynXP_cve4e5ewzdepqqNltW3UVq_Im_0EQpT2VDRPx69qO-c_JIkeF1aty8nNOb5HJ9XrFTIHvVQEeAZTmvl61gMbC1fDbtbXlfXhFA46zcSJtvjxN3HCNttdO2RWtsQEtABkJpaSl85INGuZ7KPzwUMP962_Y0gvIVsim5Gu5x9enC0A9gE2zXbQszkD1DWe5wEMzGhbh9-N6QADWxmw_s-6tWD2nr49ekd76Hn38wBaytoMAM6YfDtAM5f76KVPQ4LvLqZeoYkuX6MXi84db9AviK1gHFtBH1vBOLaCPraCogza2AqGsfUWXZ2eXC6W2AtvYJkkpMHwnLKEpjqSqRJzAzt4nillShhFU64oTzMwhEolWsKQoVIuCIBNxYSkEdXxO7RbVqX-gIKEZCRWjGZcRAlhUoQ6VgKyEJnOORF8ir5A6-S3sshtoXO7v67y2zqHdO5HzqxcQRRP0XvXZvmDK8GSd407RWzUmv0J9mLjT8ripq2e7h3_8cnf_IT2No_RZ7Tb1Gt9AMi0EYdo5_zi7LANpb8bfpHl |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+origin-of-cell+harboring+cancer-driving+mutations+in+human+glioblastoma&rft.jtitle=BMB+reports&rft.au=Lee%2C+Joo+Ho&rft.au=Lee%2C+Jeong+Ho&rft.date=2018-10-01&rft.pub=Korean+Society+for+Biochemistry+and+Molecular+Biology&rft.issn=1976-6696&rft.eissn=1976-670X&rft.volume=51&rft.issue=10&rft.spage=481&rft.epage=483&rft_id=info:doi/10.5483%2FBMBRep.2018.51.10.233&rft_id=info%3Apmid%2F30269745&rft.externalDocID=PMC6235089 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1976-6696&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1976-6696&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1976-6696&client=summon |